Last reviewed · How we verify
9,10-Dihydroergocornine (dihydroergocornine)
At a glance
| Generic name | dihydroergocornine |
|---|---|
| Drug class | dihydroergocornine |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Dementia
Common side effects
- Nausea
- Gastric disturbances
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 9,10-Dihydroergocornine CI brief — competitive landscape report
- 9,10-Dihydroergocornine updates RSS · CI watch RSS
- portfolio CI